{"title":"Xenotransplantation: a rational choice?","authors":"Ololade Olakanmi","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>There are many potential benefits that xenotransplantation (cross-species transplantation) might afford us, but there are also many weighty biological hurdles which must be surmounted if this procedure is ever to become a clinical reality. Many of these biological concerns are being addressed by specific and novel therapies; however, we must still determine the point at which xenotransplantation could be considered safe enough for clinical implementation. Many members of the scientific community believe that we should strive to make xenotransplantation products as safe and effective as possible, whereas others argue that we should not need to optimize the safety and efficaciousness of xenotransplantation products for them to be deemed acceptable for human use. In this paper I take the latter position, I argue that \"the scientific community should move from the paradigm of...trying to indicate to society optimal solutions to that of...trying to help society in finding 'satisficing' solutions\" which, although not necessarily optimal, are, nevertheless, good enough (Giampietro, 2002, p. 466).</p>","PeriodicalId":87452,"journal":{"name":"Penn bioethics journal","volume":"2 2","pages":"38-41"},"PeriodicalIF":0.0000,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Penn bioethics journal","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
There are many potential benefits that xenotransplantation (cross-species transplantation) might afford us, but there are also many weighty biological hurdles which must be surmounted if this procedure is ever to become a clinical reality. Many of these biological concerns are being addressed by specific and novel therapies; however, we must still determine the point at which xenotransplantation could be considered safe enough for clinical implementation. Many members of the scientific community believe that we should strive to make xenotransplantation products as safe and effective as possible, whereas others argue that we should not need to optimize the safety and efficaciousness of xenotransplantation products for them to be deemed acceptable for human use. In this paper I take the latter position, I argue that "the scientific community should move from the paradigm of...trying to indicate to society optimal solutions to that of...trying to help society in finding 'satisficing' solutions" which, although not necessarily optimal, are, nevertheless, good enough (Giampietro, 2002, p. 466).
异种移植(跨物种移植)可能给我们带来许多潜在的好处,但如果这一手术成为临床现实,也有许多沉重的生物学障碍必须克服。许多这些生物学问题正在通过特殊和新颖的疗法得到解决;然而,我们仍然必须确定异种移植可以被认为是足够安全的临床实施的点。科学界的许多成员认为,我们应该努力使异种移植产品尽可能安全和有效,而另一些人则认为,我们不应该优化异种移植产品的安全性和有效性,因为它们被认为可用于人类。在本文中,我采取后一种立场,我认为“科学界应该从……试图向社会指出……的最佳解决方案。试图帮助社会找到“令人满意的”解决方案,尽管不一定是最佳的,但仍然足够好(Giampietro, 2002, p. 466)。